
An individual patient data meta-analysis of 14 RCTs (n=3455) developed and validated a gonadotropin dose-selection model for IVF/ICSI. While the model poorly predicted live birth rates, it effectively minimized treatment risks, particularly ovarian hyperstimulation syndrome (OHSS). Key predictors included age, AMH, AFC, starting dose, and GnRH analog. The model provides a personalized approach to gonadotropin dosing, reducing complications and potentially lowering treatment costs without compromising efficacy.
Like
Save
Share